Wegovy® tablets (oral semaglutide)

Our review

Wegovy® tablets (oral semaglutide), first available in December 2025, is the first oral GLP-1 indicated for chronic weight management. It's the option for people who will not do needles, with the trade-off of a strict daily administration routine. Its labeled indication, dosing, contraindications, and side-effect profile should be reviewed with a licensed prescriber. This review is limited to the branded product and its labeled indications.

How it works

Wegovy® tablets deliver semaglutide in an oral formulation with specific administration requirements. Absorption is limited and variable, which is why the labeled empty-stomach and water instructions are important.

What the clinical trials show

OASIS 4 evaluated an investigational oral semaglutide drug product, and the resulting evidence subsequently supported FDA approval of Wegovy® tablets. Adults taking the studied maintenance dose lost an average of about 14 percent of body weight over 64 weeks. These figures apply only to the investigational drug product, population, dosing, and conditions studied and do not apply to compounded formulations. Individual outcomes vary and are never guaranteed.

What it's like to take

Here's the catch nobody leads with. You take it first thing in the morning, on a genuinely empty stomach, with no more than a small sip of plain water, and then nothing else, no food, no coffee, no other pills, for thirty minutes. Miss that window and absorption falls off a cliff. For disciplined morning people it's easy; for everyone else it's a daily trap.

Side effects, honestly

The digestive side effects are the same family as the rest of the class, generally on the milder side given how little is absorbed. The bigger day-to-day friction is almost always the dosing routine rather than nausea.

Who it's for, and who it isn't

This is built for people who won't inject, and for them it's now a fully approved weight-management option rather than a workaround. The trade-off is the strict daily routine, which quietly erodes results for people who can't keep it. A prescriber can help weigh the tablet against a weekly injectable based on your habits and history.

The cost reality

The published list price for the branded product (Wegovy® tablets) is around $1,349 a month. Manufacturer self-pay programs and savings cards may be available to eligible patients, and insurance coverage for chronic weight management varies. Confirm current terms with the manufacturer, insurer, and dispensing pharmacy.

The bottom line

Oral semaglutide solves exactly one problem, the needle, at the cost of a strict daily routine. For the right person that trade is clearly worth it. Discuss with a licensed prescriber whether the tablet or an injectable option better fits your situation.

How it compares

Patient reviews